Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03463681 |
|---|---|
| Brief Title: | A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma (BREAKPOINT) |
| First Submitted : | March 5, 2018 |
| First Submitted that Met QC Criteria : | March 12, 2018 |
| First Posted : | March 13, 2018 |
| Last Update Submitted that Met QC Criteria : | April 23, 2021 |
| Last Update Posted : | April 26, 2021 |